Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT04996797
PHASE2

A Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Moderately to Severely Active Ulcerative Colitis (MK-7240-005)

Sponsor: Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

View on ClinicalTrials.gov

Summary

The purpose of this study is to assess the safety and efficacy of tulisokibart in participants with moderately to severely active Ulcerative Colitis (UC). After the completion of the 12-week induction, all participants have the option to continue in the open-label extension for up to 170 weeks.

Official title: A Phase 2, Multi-Center, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Induction Therapy With PRA023 in Subjects With Moderately to Severely Active Ulcerative Colitis

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

178

Start Date

2021-07-14

Completion Date

2025-07-14

Last Updated

2026-09-01

Healthy Volunteers

No

Interventions

DRUG

Tulisokibart

Administered by IV infusion

DEVICE

Companion Diagnostic (CDx) Testing

PRA023 CDx Genotyping Assay

OTHER

Placebo

Placebo administered by IV infusion

Locations (88)

Prometheus Biosciences Selected Center

Mobile, Alabama, United States

Prometheus Biosciences Selected Site

Phoenix, Arizona, United States

Prometheus Biosciences Selected Site

Sun City, Arizona, United States

Prometheus Biosciences Selected Site

Los Angeles, California, United States

Prometheus Biosciences Selected Site

Los Angeles, California, United States

Prometheus Biosciences Selected Site

San Diego, California, United States

Prometheus Biosciences Selected Site

Bristol, Connecticut, United States

Prometheus Biosciences Selected Site

Atlanta, Georgia, United States

Prometheus Biosciences Selected Site

Arlington Heights, Illinois, United States

Prometheus Biosciences Selected Site

Glenview, Illinois, United States

Prometheus Biosciences Selected Site

Gurnee, Illinois, United States

Prometheus Biosciences Selected Site

Kansas City, Kansas, United States

Prometheus Biosciences Selected Site

Liberty, Kansas, United States

Prometheus Biosciences Selected Site

Baton Rouge, Louisiana, United States

Prometheus Biosciences Selected Site

Chevy Chase, Maryland, United States

Prometheus Biosciences Selected Site

Chesterfield, Michigan, United States

Prometheus Biosciences Selected Site

Lebanon, New Hampshire, United States

Prometheus Biosciences Selected Site

New York, New York, United States

Prometheus Biosciences Selected Site

New York, New York, United States

Prometheus Biosciences Selected Site

Dublin, Ohio, United States

Prometheus Biosciences Selected Site

Germantown, Tennessee, United States

Prometheus Biosciences Selected Site

Bedford, Texas, United States

Prometheus Biosciences Selected Site

Lubbock, Texas, United States

Prometheus Biosciences Selected Site

Mansfield, Texas, United States

Prometheus Biosciences Selected Site

San Antonio, Texas, United States

Prometheus Biosciences Selected Site

Southlake, Texas, United States

Prometheus Biosciences Selected Site

Tyler, Texas, United States

Prometheus Biosciences Selected Site

Charlottesville, Virginia, United States

Prometheus Biosciences Selected Site

Tacoma, Washington, United States

Prometheus Biosciences Selected Site

Woodville, Adelaide, Australia

Prometheus Biosciences Selected Site

Kingswood, New South Wales, Australia

Prometheus Biosciences Selected Site

Old Toongabbie, New South Wales, Australia

Prometheus Biosciences Selected Site

South Brisbane, Queensland, Australia

Prometheus Biosciences Selected Site

Woolloongabba, Queensland, Australia

Prometheus Biosciences Selected Site

Adelaide, South Australia, Australia

Prometheus Biosciences Selected Site

Fitzroy, Victoria, Australia

Prometheus Biosciences Selected Site

Melbourne, Victoria, Australia

Prometheus Biosciences Selected Site

Leuven, Belgium

Prometheus Biosciences Selected Site

Liège, Belgium

Prometheus Biosciences Selected Site

Calgary, Alberta, Canada

Prometheus Biosciences Selected Site

Vancouver, British Columbia, Canada

Prometheus Biosciences Selected Site

Halifax, Nova Scotia, Canada

Prometheus Biosciences Selected Site

North York, Ontario, Canada

Prometheus Biosciences Selected Site

Brno, Czechia

Prometheus Biosciences Selected Site

Hradec Králové, Czechia

Prometheus Biosciences Selected Site

Olomouc, Czechia

Prometheus Biosciences Selected Site

Slaný, Czechia

Prometheus Biosciences Selected Site

Clichy, France

Prometheus Biosciences Selected Site

Lille, France

Prometheus Biosciences Selected Site

Nice, France

Prometheus Biosciences Selected Site

Pierre-Bénite, France

Prometheus Biosciences Selected Site

Saint-Priest-en-Jarez, France

Prometheus Biosciences Selected Site

Vandœuvre-lès-Nancy, France

Prometheus Biosciences Selected Site

Tbilisi, Georgia

Prometheus Biosciences Selected Site

Győr, Győr-Moson-Sopron, Hungary

Prometheus Biosciences Selected Site

Békéscsaba, Hungary

Prometheus Biosciences Selected Site

Budapest, Hungary

Prometheus Biosciences Selected Site

Budapest, Hungary

Prometheus Biosciences Selected Center

Budapest, Hungary

Prometheus Biosciences Selected Site

Afula, Israel

Prometheus Biosciences Selected Site

Beersheba, Israel

Prometheus Biosciences Selected Site

Holon, Israel

Prometheus Biosciences Selected Site

Jerusalem, Israel

Prometheus Biosciences Selected Site

Petah Tikva, Israel

Prometheus Biosciences Selected Site

Bologna, Emilia-Romagna, Italy

Prometheus Biosciences Selected Site

Milan, Milan, Italy

Prometheus Biosciences Selected Site

Milan, Milan, Italy

Prometheus Biosciences Selected Site

Roma, Rome, Italy

Prometheus Biosciences Selected Site

Poznan, Greater Poland Voivodeship, Poland

Prometheus Biosciences Selected Site

Włocławek, Kuuavian-Pomeranian, Poland

Prometheus Biosciences Selected Site

Krakow, Lesser Poland Voivodeship, Poland

Prometheus Biosciences Selected Site

Wroclaw, Lower Silesian Voivodeship, Poland

Prometheus Biosciences Selected Site

Wroclaw, Lower Silesian Voivodeship, Poland

Prometheus Biosciences Selected Site

Warsaw, Masovia, Poland

Prometheus Biosciences Selected Site

Katowice, Silesian, Poland

Prometheus Biosciences Selected Site

Krakow, Poland

Prometheus Biosciences Selected Site

Lodz, Poland

Prometheus Biosciences Selected Site

Lublin, Poland

Prometheus Biosciences Selected Site

Lublin, Poland

Prometheus Biosciences Selected Site

Rzeszów, Poland

Prometheus Biosciences Selected Site

Sopot, Poland

Prometheus Biosciences Selected Site

Szczecin, Poland

Prometheus Biosciences Selected Site

Torun, Poland

Prometheus Biosciences Selected Site #2

Warsaw, Poland

Prometheus Biosciences Selected Site

Warsaw, Poland

Prometheus Biosciences Selected Site

Wroclaw, Poland

Prometheus Biosciences Selected Site

Prescot, Merseyside, United Kingdom

Prometheus Biosciences Selected Sites

London, United Kingdom